i2o-130

N/A

Report date: 2023/11/10 15:45:38

Base Information

Drug Namei2o-130
Drug Alias Namei2o-130
ClassificationBiologics
Mechanisms of ActionGlucagon receptor modulators
TargetsGlucagon receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companiesi2o Therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companiesi2o Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A